胰岛素样生长因子-1通过减少AMPK/FOXO1信号传导和Na+/K+-ATPase-Beclin-1相互作用减少心脏自律性。

IF 3 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Archives of Medical Science Pub Date : 2024-01-12 eCollection Date: 2024-01-01 DOI:10.5114/aoms/177618
Katarina Banjac, Milan Obradovic, Sonja Zafirovic, Esma R Isenovic
{"title":"胰岛素样生长因子-1通过减少AMPK/FOXO1信号传导和Na+/K+-ATPase-Beclin-1相互作用减少心脏自律性。","authors":"Katarina Banjac, Milan Obradovic, Sonja Zafirovic, Esma R Isenovic","doi":"10.5114/aoms/177618","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Insulin-like growth factor-1 (IGF-1) promotes survival and inhibits cardiac autophagy disruption.</p><p><strong>Methods: </strong>Male Wistar rats were treated with IGF-1 (50 µg/kg), and 24 h after injection hearts were excised. The level of interaction between Beclin-1 and the α<sub>1</sub> subunit of sodium/potassium-adenosine triphosphates (Na<sup>+</sup>/K<sup>+</sup>-ATPase), and phosphorylated forms of IGF-1 receptor/insulin receptor (IGF-1R/IR), forkhead box protein O1 (FOXO1) and AMP-activated protein kinase (AMPK) were measured.</p><p><strong>Results: </strong>The results indicate that IGF-1 decreased Beclin-1's association with Na<sup>+</sup>/K<sup>+</sup>-ATPase (<i>p</i> < 0.05), increased IGF-1R/IR and FOXO1 phosphorylation (<i>p</i> < 0.05), and decreased AMPK phosphorylation (<i>p</i> < 0.01) in rats' hearts.</p><p><strong>Conclusions: </strong>The new IGF-1 therapy may control autosis and minimize cardiomyocyte mortality.</p>","PeriodicalId":8278,"journal":{"name":"Archives of Medical Science","volume":"20 3","pages":"1011-1015"},"PeriodicalIF":3.0000,"publicationDate":"2024-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11264057/pdf/","citationCount":"0","resultStr":"{\"title\":\"Insulin-like growth factor-1 reduces cardiac autosis through decreasing AMPK/FOXO1 signaling and Na<sup>+</sup>/K<sup>+</sup>-ATPase-Beclin-1 interaction.\",\"authors\":\"Katarina Banjac, Milan Obradovic, Sonja Zafirovic, Esma R Isenovic\",\"doi\":\"10.5114/aoms/177618\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Insulin-like growth factor-1 (IGF-1) promotes survival and inhibits cardiac autophagy disruption.</p><p><strong>Methods: </strong>Male Wistar rats were treated with IGF-1 (50 µg/kg), and 24 h after injection hearts were excised. The level of interaction between Beclin-1 and the α<sub>1</sub> subunit of sodium/potassium-adenosine triphosphates (Na<sup>+</sup>/K<sup>+</sup>-ATPase), and phosphorylated forms of IGF-1 receptor/insulin receptor (IGF-1R/IR), forkhead box protein O1 (FOXO1) and AMP-activated protein kinase (AMPK) were measured.</p><p><strong>Results: </strong>The results indicate that IGF-1 decreased Beclin-1's association with Na<sup>+</sup>/K<sup>+</sup>-ATPase (<i>p</i> < 0.05), increased IGF-1R/IR and FOXO1 phosphorylation (<i>p</i> < 0.05), and decreased AMPK phosphorylation (<i>p</i> < 0.01) in rats' hearts.</p><p><strong>Conclusions: </strong>The new IGF-1 therapy may control autosis and minimize cardiomyocyte mortality.</p>\",\"PeriodicalId\":8278,\"journal\":{\"name\":\"Archives of Medical Science\",\"volume\":\"20 3\",\"pages\":\"1011-1015\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-01-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11264057/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Medical Science\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.5114/aoms/177618\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Medical Science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5114/aoms/177618","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

引言胰岛素样生长因子-1(IGF-1)可促进心脏存活并抑制心脏自噬破坏:雄性Wistar大鼠接受IGF-1(50 µg/kg)治疗,注射24小时后切除心脏。方法:用IGF-1(50 µg/kg)治疗雄性Wistar大鼠,注射24小时后切除心脏,测定Beclin-1与钠/钾-腺苷三磷酸酶(Na+/K+-ATPase)α1亚基的相互作用水平,以及IGF-1受体/胰岛素受体(IGF-1R/IR)、叉头盒蛋白O1(FOXO1)和AMP激活蛋白激酶(AMPK)的磷酸化形式:结果表明,IGF-1能降低大鼠心脏中Beclin-1与Na+/K+-ATPase的结合(p < 0.05),增加IGF-1R/IR和FOXO1的磷酸化(p < 0.05),降低AMPK的磷酸化(p < 0.01):结论:IGF-1新疗法可控制自体坏死,并将心肌细胞死亡率降至最低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Insulin-like growth factor-1 reduces cardiac autosis through decreasing AMPK/FOXO1 signaling and Na+/K+-ATPase-Beclin-1 interaction.

Introduction: Insulin-like growth factor-1 (IGF-1) promotes survival and inhibits cardiac autophagy disruption.

Methods: Male Wistar rats were treated with IGF-1 (50 µg/kg), and 24 h after injection hearts were excised. The level of interaction between Beclin-1 and the α1 subunit of sodium/potassium-adenosine triphosphates (Na+/K+-ATPase), and phosphorylated forms of IGF-1 receptor/insulin receptor (IGF-1R/IR), forkhead box protein O1 (FOXO1) and AMP-activated protein kinase (AMPK) were measured.

Results: The results indicate that IGF-1 decreased Beclin-1's association with Na+/K+-ATPase (p < 0.05), increased IGF-1R/IR and FOXO1 phosphorylation (p < 0.05), and decreased AMPK phosphorylation (p < 0.01) in rats' hearts.

Conclusions: The new IGF-1 therapy may control autosis and minimize cardiomyocyte mortality.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Archives of Medical Science
Archives of Medical Science 医学-医学:内科
CiteScore
4.90
自引率
7.90%
发文量
139
审稿时长
1.7 months
期刊介绍: Archives of Medical Science (AMS) publishes high quality original articles and reviews of recognized scientists that deal with all scientific medicine. AMS opens the possibilities for young, capable scientists. The journal would like to give them a chance to have a publication following matter-of-fact, professional review by outstanding, famous medical scientists. Thanks to that they will have an opportunity to present their study results and/or receive useful advice about the mistakes they have made so far. The second equally important aim is a presentation of review manuscripts of recognized scientists about the educational capacity, in order that young scientists, often at the beginning of their scientific carrier, could constantly deepen their medical knowledge and be up-to-date with current guidelines and trends in world-wide medicine. The fact that our educational articles are written by world-famous scientists determines their innovation and the highest quality.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信